Display options
Cite
Galvan V, Quarleri J. Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans. Geroscience. 2021;doi: 10.1007/s11357-021-00501-3.
Galvan, V., & Quarleri, J. (2021). Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans. GeroScience, . https://doi.org/10.1007/s11357-021-00501-3
Galvan, Veronica, and Quarleri, Jorge. "Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans." GeroScience vol. (2021). doi: https://doi.org/10.1007/s11357-021-00501-3
Galvan V, Quarleri J. Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans. Geroscience. 2021 Dec 21; doi: 10.1007/s11357-021-00501-3. Epub 2021 Dec 21. PMID: 34935099; PMCID: PMC8691152.
Copy Download .nbib Format: NLM
Share it on

Geroscience. 2021 Dec 21; doi: 10.1007/s11357-021-00501-3. Epub 2021 Dec 21.

Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans.

GeroScience

Veronica Galvan, Jorge Quarleri

Affiliations

  1. Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  2. Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  3. Research Health Scientist, US Department of Veterans Affairs, Oklahoma City VA Health Care System, Oklahoma City, OK, USA.
  4. Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Facultad de Medicina, Consejo de Investigaciones Científicas y Técnicas (CONICET), Universidad de Buenos Aires, Buenos Aires, Argentina. [email protected].

PMID: 34935099 PMCID: PMC8691152 DOI: 10.1007/s11357-021-00501-3

Abstract

Vaccine development has become the main tool for reducing COVID-19 cases and the severity of the disease. Comparative analyses of adaptive immunity generated by different vaccines platforms are urgently needed. Multiple studies have compared different vaccines using similar platforms; however, comparative analyses of vaccines across different platforms are lacking. This Editorial provides a summary and commentary on the main findings reported in the observational and longitudinal study by Vályi-Nagy et al. (Geroscience 43:2321) that compared the adaptive (humoral and T cell-mediated) immune responses elicited by Sinopharm and BNT162b2 vaccines against SARS-CoV-2 virus among 57 healthy adult Hungarian volunteers.

© 2021. The Author(s), under exclusive licence to American Aging Association.

References

  1. JAMA Netw Open. 2021 Oct 1;4(10):e2130800 - PubMed
  2. Lancet. 2020 Aug 15;396(10249):467-478 - PubMed
  3. NPJ Vaccines. 2021 Feb 22;6(1):28 - PubMed
  4. Nature. 2020 Oct;586(7830):589-593 - PubMed
  5. J Immunol. 2021 Jul 15;207(2):376-379 - PubMed
  6. iScience. 2021 Apr 23;24(4):102298 - PubMed
  7. Cell. 2020 Aug 6;182(3):713-721.e9 - PubMed
  8. Nature. 2020 Oct;586(7830):516-527 - PubMed
  9. Geroscience. 2021 Oct;43(5):2321-2331 - PubMed
  10. N Engl J Med. 2020 Dec 31;383(27):2603-2615 - PubMed
  11. Nature. 2021 Dec;600(7889):530-535 - PubMed
  12. Nat Med. 2021 Feb;27(2):270-278 - PubMed
  13. JAMA. 2020 Sep 8;324(10):951-960 - PubMed
  14. N Engl J Med. 2020 Nov 12;383(20):1920-1931 - PubMed
  15. Cell. 2020 Jun 25;181(7):1489-1501.e15 - PubMed
  16. Immunity. 2020 Aug 18;53(2):248-263 - PubMed
  17. PLoS Pathog. 2021 Apr 16;17(4):e1009448 - PubMed
  18. Cell Rep Med. 2021 Jul 20;2(7):100354 - PubMed
  19. Lancet. 2021 Jul 17;398(10296):213-222 - PubMed
  20. Clin Infect Dis. 2021 Sep 19;: - PubMed
  21. N Engl J Med. 2021 Sep 2;385(10):875-884 - PubMed
  22. Lancet Infect Dis. 2021 Jan;21(1):39-51 - PubMed
  23. Vaccine. 2021 Nov 5;39(46):6713-6719 - PubMed
  24. Lancet Infect Dis. 2021 Feb;21(2):181-192 - PubMed
  25. Sci Transl Med. 2021 Sep;13(609):eabj0847 - PubMed
  26. Vaccines (Basel). 2021 Sep 16;9(9): - PubMed
  27. Hum Vaccin Immunother. 2015;11(2):477-88 - PubMed
  28. Science. 2021 Mar 25;: - PubMed

Publication Types